...
首页> 外文期刊>Theoretical Biology and Medical Modelling >Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy
【24h】

Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy

机译:与日本A炸弹和霍奇金组合队列相关的与放射疗法相关剂量的癌症诱导的部位特异性剂量反应关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and Purpose Most information on the dose-response of radiation-induced cancer is derived from data on the A-bomb survivors. Since, for radiation protection purposes, the dose span of main interest is between zero and one Gy, the analysis of the A-bomb survivors is usually focused on this range. However, estimates of cancer risk for doses larger than one Gy are becoming more important for radiotherapy patients. Therefore in this work, emphasis is placed on doses relevant for radiotherapy with respect to radiation induced solid cancer. Materials and methods For various organs and tissues the analysis of cancer induction was extended by an attempted combination of the linear-no-threshold model from the A-bomb survivors in the low dose range and the cancer risk data of patients receiving radiotherapy for Hodgkin's disease in the high dose range. The data were fitted using organ equivalent dose (OED) calculated for a group of different dose-response models including a linear model, a model including fractionation, a bell-shaped model and a plateau-dose-response relationship. Results The quality of the applied fits shows that the linear model fits best colon, cervix and skin. All other organs are best fitted by the model including fractionation indicating that the repopulation/repair ability of tissue is neither 0 nor 100% but somewhere in between. Bone and soft tissue sarcoma were fitted well by all the models. In the low dose range beyond 1 Gy sarcoma risk is negligible. For increasing dose, sarcoma risk increases rapidly and reaches a plateau at around 30 Gy. Conclusions In this work OED for various organs was calculated for a linear, a bell-shaped, a plateau and a mixture between a bell-shaped and plateau dose-response relationship for typical treatment plans of Hodgkin's disease patients. The model parameters (α and R) were obtained by a fit of the dose-response relationships to these OED data and to the A-bomb survivors. For any three-dimensional inhomogenous dose distribution, cancer risk can be compared by computing OED using the coefficients obtained in this work.
机译:背景和目的有关辐射诱发癌症剂量反应的大多数信息均来自有关原子弹幸存者的数据。由于出于辐射防护目的,主要关注的剂量范围在0至1 Gy之间,因此对A炸弹幸存者的分析通常集中在该范围内。但是,对于大于1 Gy的剂量,对放射风险的癌症估计对于放射治疗患者变得越来越重要。因此,在这项工作中,重点放在与放射线诱发的实体癌放疗有关的剂量上。材料和方法对于各种器官和组织,通过尝试将低剂量范围内A型炸弹幸存者的线性无阈值模型与接受放射疗法治疗霍奇金病患者的癌症风险数据相结合,扩展了对癌症诱发的分析在高剂量范围内。使用为一组不同的剂量反应模型(包括线性模型,包括分馏的模型,钟形模型和平台剂量反应关系)计算的器官当量剂量(OED)拟合数据。结果所应用拟合的质量显示线性模型最适合结肠,子宫颈和皮肤。该模型可以很好地拟合所有其他器官,包括分馏表明该组织的再填充/修复能力既不是0也不是100%,而是介于两者之间。所有模型均很好地拟合了骨和软组织肉瘤。在超过1 Gy的低剂量范围内,肉瘤的风险可以忽略不计。随着剂量的增加,肉瘤的风险会迅速增加,并在30 Gy左右达到平稳期。结论在这项工作中,针对霍奇金病患者的典型治疗计划,计算了线性,钟形,平稳以及钟形和高原剂量反应关系之间的混合物的各种器官的OED。通过与这些OED数据和原子弹幸存者的剂量反应关系拟合,获得模型参数(α和R)。对于任何三维不均匀剂量分布,可以使用在这项工作中获得的系数通过计算OED来比较癌症风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号